• About
  • Subscribe
  • Advertise
  • Contact
Saturday, May 24, 2025
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Ophthalmic education Orthoptics Australia

OAW: The crucial role of orthoptists in paediatric vision screening

by Staff Writer
June 1, 2020
in Feature, Local, News, Orthoptics Australia
Reading Time: 4 mins read
A A
Share on FacebookShare on Twitter

Orthoptics Awareness Week is taking place between 1-5 June with the theme ‘Seeing the future’. To kick off the five-part series, LOUSIE BRENNAN discusses the important role of orthoptists in paediatric vision screenings and the success of the New South Wales StEPs program. 

Louise Brennan.

The primary goal of paediatric vision screening is to detect disorders of vision that can lead to amblyopia.

Orthoptists can play a key role in amblyopia detection and management thanks to university training programs, workplace experience and continuing education opportunities. The orthoptist skillset means they can competently assess vision from birth into adulthood with specialised testing and adaptive techniques.

The techniques of play, distraction, adaptability and a ‘never give up’ attitude are key in paediatrics. These allow orthoptists to gain accurate vision assessment, enabling timely diagnosis and appropriate intervention.

Universal vision screening involves thorough planning and accessibility through all stages, including implementation, detection and timely treatment. In New South Wales, StEPS (State-wide Eyesight Preschooler Screening) is one such program, which offers all four-year-old children free vision screening before they reach school.

The success of the program has been evidenced in an external evaluation in 2018 that showed that the program “was working well and that there were many benefits for families and children that participated in the program”.

The Children’s Hospital at Westmead (CHW) has now been involved in StEPs for 12 years. It sees high priority referrals of four year olds that have undergone primary community-based screening with a vision fail of 6/18 or worse. They are managed within the tertiary level clinics by paediatric orthoptists and ophthalmologists.

On a personal note, orthoptists working within the high priority referral clinic at CHW have a great sense of achievement. Families have anecdotally shown their gratitude; firstly to the community-based screeners for detecting their child’s vision problem; and secondly to the paediatric orthoptists and ophthalmologists involved in their care.

Orthoptists working in this clinic feel privileged to deliver first-class care to NSW children and gain good visual outcome for the child by the time they are eight years old. The program adopts a holistic approach and is accessible for all. Those with a disability or additional needs can also be assessed via secondary and tertiary screening to ensure no child is missed.

The four year old test is crucial because at this age children have the cognitive function to perform gold standard crowded acuity letter matching tests. It’s also an ideal window of opportunity for treatment during the critical period of vision development.

The vast majority of children referred to the CHW high priority clinic with a visual acuity of 6/18 or less have a diagnosis of refractive error with amblyopia.

A small proportion are children who were unable to be screened at the community-based screening, while another small proportion have other ocular disorders or pathology.

The most common refractive errors are hypermetropic astigmatism, myopic astigmatism and anisometropia. It’s no surprise, particularly with the high anisometropic cases, that children in this age group do not complain of vision problems; due to having one ‘good’ eye, their poor monocular vision goes unnoticed by parents and care givers too.

This demonstrates the importance of a universal vision screening program.

The main form of management is to correct the refractive error with glasses that are worn fulltime for all activities.

A glasses adaptation period of 12 weeks is allowed and, if sub normal vision persists in one eye, then amblyopia is diagnosed and part-time occlusion therapy of the better eye is commenced.

In some cases of high anisometropic amblyopia with poor visual acuity and assumed dense amblyopia, part-time occlusion therapy is commenced immediately at the same time as the glasses are commenced.

With close monitoring and support from orthoptists in regard to occlusion therapy, outcomes in this age group are excellent. The majority achieve a final best corrected visual outcome in their worse eye of 6/7.6 or better.

Between the ages of eight to 10 children, who can demonstrate their vision has stabilised after active occlusion therapy and can competently perform a subjective refraction, are discharged to their local eyecare provider.

Paediatric orthoptists possess great communication and counselling skills, allowing rapport to be built with children and families. This facilitates the provision of accurate information to reassure to families, while ultimately contributing to the best outcome for the child.

ABOUT THE AUTHOR: Louise Brennan is a Senior Paediatric Orthoptist who has worked at The Children’s Hospital at Westmead for the past 25 years.

More reading: Orthoptics Awareness Week spotlights paediatric eye health

Related Posts

Jillian Campbell, performing as many as 20 contact lens fits a day, relies on the Medmont Merdia Pro for most of her work.

The workhorse of this contact lens practice

by Staff Writer
May 24, 2025

The next-generation Meridia Pro boasts all the advantages Medmont corneal topography is famous for, plus more. Independents like JILLIAN CAMPBELL...

Rodenstock’s new B.I.G. Exact Sensitive lenses are now available in Australia. Image: Rodenstock.

Try before you buy – a personal, exacting trial for Rodenstock lenses

by Rob Mitchell
May 23, 2025

Rodenstock has made some significant statements about its new B.I.G Exact Sensitive lenses. The director of a Melbourne optometry practice...

The Eyerising Myopia Management Device was approved in Australia in 2023. Image: Eyerising International.

Eyerising International addresses ‘limitations’ of red light study suggesting reduced cone density  

by Staff Writer
May 23, 2025

The inventor of the Eyerising International repeated low-level red light (RLRL) therapy for myopia, Professor Mingguang He, has outlined “notable...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited